Canton Strategic Holdings, Inc.

CNTN

Healthcare Biotechnology

EPS
+85.9%
Free cash flow
−600.4%

Quarter to June 2026, against a year earlier

2.06 0.13 +6.74%
Market cap
$164.1M
P/E
n/m
Fwd P/E
—
Dividend yield
—
F-score
n/a
ROIC
−8.11%
Net debt / EBITDA
0.8×
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
0.00 — — —

+8 more quarters

P/S ratio
0.00 — — —
P/FCF ratio
0.00 — — —
P/Operating CF
(273.22) — — —
P/B ratio
1.34 — — —
EV/Sales
0.00 — — —
EV/EBITDA
0.00 — — —
EV/FCF
(25.94) — — —
Current Ratio
15.70 37.75 5.29 4.98
Net Debt/EBITDA
30.98 1.13 0.86 3.62
Debt/Equity
0.00 0.00 0.00 0.01
Earnings Yield
(32.36%) — — —
Free Cash Flow Yield
(3.63%) — — —
Free Cash Flow per Share
(0.04) (0.30) (2.75) (0.30)
Book value per Share
2.10 2.26 12.42 0.99
Free Cash Flow
(8.00) (62.46) (88.01) (1.86)
EV/EBIT
0.00 — — —
Other line items

Show all line items

Columns are period end dates · fundamentals updated 26 Oct 2026